Napp’s Pelmeg, a biosimilar of Amgen’s cancer drug Neulasta (pegfilgrastim), has been launched in the UK following approval late last year. This is Napp’s first launch of a product developed by Cinfa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback